People seeking treatment for depression often experience symptom relief whether they receive an active medication or an inactive placebo. By pooling data from various symptom surveys, researchers discovered that while the pattern of mood improvement looks remarkably similar in both scenarios, the active medication triggers a more intense recovery that is uniquely linked to a patient’s baseline brain connectivity. These findings were published in the journal Psychological Medicine. Measuring mood improvement is notoriously difficult. Clinicians typically rely on standard questionnaires that condense a wide range of symptoms into a single score. This approach can blur the lines between different aspects of mental health, such as sadness, anxiety, and suicidal thoughts. It also makes it difficult to separate the effects of a pharmacological drug from the placebo effect. The placebo effect occurs when a patient’s condition improves simply because they expect the treatment to work. Past studies comparing antidepressants to placebos often show little statistical difference when using broad, conventional rating scales. When patients take a pill, the expectation of feeling better often drives real neurobiological …